Cited by 291Immune Response and InflammationNF-κB Signaling PathwaysSepsis Diagnosis and Treatment

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

A Novel Receptor Tyrosine Kinase, Mer, Inhibits TNF-α Production and Lipopolysaccharide-Induced Endotoxic Shock

Open access

Abstract

Abstract The regulation of monocyte function and the inhibition of TNF-α production during bacterial sepsis are critical in attenuating adverse host responses to endotoxemia. To study the function of a novel receptor tyrosine kinase, mer, that is expressed in monocytes, we generated mice (merkd) that lack the signaling tyrosine kinase domain. Upon LPS challenge, merkd animals died of endotoxic shock (15/17, 88.2%), whereas control wild-type mice survived (1/15, 6.7% died). Susceptible merkd mice exhibited edema, leukocyte infiltration, and signs of endotoxic shock that correlated with higher levels of TNF-α found in the serum of merkd mice as compared with wild-type control animals. Death due to LPS-induced endotoxic shock in merkd mice was blocked by administration of anti-TNF-α Ab, suggesting that overproduction of this cytokine was principally responsible for the heightened suseptibility. The increase in TNF-α production appeared to be the result of a substantial increase in the LPS-dependent activation of NF-κB nuclear translocation resulting in greater TNF-α production by macrophages from merkd mice. Thus, Mer receptor tyrosine kinase signaling participates in a novel inhibitory pathway in macrophages important for regulating TNF-α secretion and attenuating endotoxic shock.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.162.6.3498

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 35

  1. 1991, Mol. Cell. Biol., 5016
  2. 1994, J. Biol. Chem., 1839
  3. 1994, Cell Growth Differ., 647
  4. 1992, J. Virol., 5975
  5. 1995, Mol. Cell. Biol., 6582
  6. 1996, J. Biol. Chem., 30022
  7. 1996, J. Biol. Chem., 29049
  8. 1995, Oncogene, 2349
  9. 1991, Lancet, 736
  10. 1991, Infect. Dis. Clin. North Am., 739
  11. 1990, Ann. Intern. Med., 491
  12. 1993, N. Engl. J. Med., 1471
  13. 1988, J. Immunol., 547
  14. 1991, Ann. Intern. Med., 457
  15. 1986, Science, 470
  16. 1991, Circ. Shock, 123
  17. 1997, J. Clin. Invest., 972
  18. 1993, Cell, 969
  19. 1987, Nature, 292
  20. 1987, Anal. Biochem., 156
  21. 1991, Proc. Natl. Acad. Sci. USA, 1873
  22. 1996, J. Biol. Chem., 18355
  23. 1995, Science, 83
  24. 1994, Annu. Rev. Med., 491
  25. 1989, J. Immunol., 3884
  26. 1991, J. Immunol., 1649
  27. 1990, Mol. Cell. Biol., 1498
  28. 1997, Cell Growth Differ., 435
  29. 1994, Annu. Rev. Immunol., 141
  30. 1995, Annu. Rev. Immunol., 437
  31. 1993, J. Immunol., 3829
  32. 1996, Immunity, 407
  33. 1997, J. Exp. Med., 1661
  34. 1998, Proc. Natl. Acad. Sci. USA, 7580
  35. 1994, Science, 1319

Cited by

Sorted by citations

See all 291

Metadata

Authors
Camenisch, T. D., Koller, B. H., Earp, H. S., & Matsushima, G. K.
Affiliations
University of North Carolina at Chapel Hill (US)
Venue
The Journal of Immunology
Published
1999-03
Volume
162
Issue
6
Pages
3498-3503
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W4313344687
Cited by
290
References
31
Citations by year
2026: 7 · 2025: 6 · 2024: 21 · 2023: 15 · 2022: 15 · 2021: 14 · 2020: 18 · 2019: 17 · 2018: 16 · 2017: 17 · 2016: 13 · 2015: 13 · 2014: 12 · 2013: 13 · 2012: 5
FWCI
1.72
Type
journal article
Language
en
Open access
Locations
The Journal of Immunology (publishedVersion)
Funders
University of North Carolina at Chapel Hill
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Keywords
Mer receptor tyrosine kinase, TNF-alpha production, endotoxic shock, lipopolysaccharide, endotoxemia, sepsis, monocytes, macrophages, NF-κB nuclear translocation, anti-TNF-alpha antibody, receptor signaling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review